PDF
ePub
Citation
Print
Abstract
Interdigitating dendritic cell sarcoma (IDCS) is an extremely rare tumor derived from professional antigen presenting cell and primarily found in lymph nodes, with rarer case report about extranodal presentation of IDCS. A 71-yr-old man was admitted with progressively enlarging and painless mass in the right parotid area for 2 months. Computed tomography of the neck and chest revealed enhancing mass in right parotid gland, multiple lymphadenopathies around neck and mediastinum, and an osteolytic metastasis at thoracic spine. Morphological and immunohistochemical analysis of an excisional biopsy specimen from parotid mass were consistent with a diagnosis of IDCS. Palliative chemotherapy with 6 cycles of CHOP (cyclophosphamide, adriamycin, vincristine, and prednisolone) regimen and 2 cycles of ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine) regimen plus radiotherapy on parotid mass failed in tumor reduction. We describe a rare case of disseminated extranodal IDCS arising from parotid gland.
References
1. Kairouz S, Hashash J, Kabbara W, McHayleh W, Tabbara IA. Dendritic cell neoplasms: an overview. Am J Hematol. 2007; 82:924–8.
2. Saygin C, Uzunaslan D, Ozguroglu M, Senocak M, Tuzuner N. Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series. Crit Rev.
3. Han HS, Lee OJ, Lim SN, An JY, Lee KM, Choe KH, al. Extranodal interdigitating dendritic cell sarcoma presenting in the pleura: a case report. J Korean Med Sci. 2011; 26:304–7.
4. Kim SY, Kang JH, Chun SH, Chang MH, Kim YS, Lee SN, et al. Interdigitating dendritic cell sarcoma of the tonsil. Asia Pac J Clin Oncol. 2010; 6:144–8.
5. Lee SY, Lee SR, Chang WJ, Kim HS, Kim BS, Kim IS. Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy. Korean J Hematol. 2012; 47:150–3.
6. Lee EJ, Hyun DW, Cho HY, Lee JG. A Rare Case of Interdigitating Dendritic Cell Sarcoma in the Nasal Cavity. Case Rep Otolaryngol. 2013; 2013:913157.
7. Han SW, Kim ZS, Kim HM, Lee J, Kang GH, Cho HD, et al. Interdigitating dendritic cell sarcoma occurred alone in axilla. J Korean Surg Soc. 2012; 82:330–4.
8. Efune G, Sumer BD, Sarode VR, Wang HY, Myers LL. Interdigitating dendritic cell sarcoma of the parotid gland: case report and literature review. Am J Otolaryngol. 2009; 30:264–8.
9. Schraven SP, Plontke SK, Syha R, Fend F, Wolburg H, Adam P. Dendritic cell tumor in a salivary gland lymph node: a rare differential diagnosis of salivary gland neoplasms. Diagn Pathol. 2011; 6:94.
10. De Pas T, Spitaleri G, Pruneri G, Curigliano G, Noberasco C, Luini A, et al. Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases. Crit Rev Oncol Hematol. 2008; 65:1–7.
11. Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002; 41:1–29.
12. Ralfkiaer E, Delsol G, O'Connor NT, Brandtzaeg P, Brousset P, Vejlsgaard GL, et al. Malignant lymphomas of true histiocytic origin. A clinical, histological, immunophenotypic and genotypic study. J Pathol. 1990; 160:9–17.
13. Barwell N, Howatson R, Jackson R, Johnson A, Jarrett RF, Cook G. Interdigitating dendritic cell sarcoma of salivary gland associated lymphoid tissue not associated with HHV-8 or EBV infection. J Clin Pathol. 2004; 57:87–9.
Table 1.
Demographic and clinical features of reported and Korean cases.
| Reported cases (N = 100) | Korean cases (N = 5) | |
|---|---|---|
| Age | ||
| Median (range), yr | 56.5 (1.8 – 88) | 57 (32 – 73) |
| Sex | ||
| Male:female (ratio) | 58:42 (1.38:1) | 2:3 (1:1.5) |
| Presentationa | ||
| Localized | 59% (45/76) | 20% (1/5) |
| Locally advanced | 5.3% (4/76) | 40% (2/5) |
| Metastatic | 35.6% (27/76) | 40% (2/5) |
| Involved sites (number of cases) | ||
| Lymph nodes | ||
| Cervical | 41 | 2 |
| Axillary | 22 | 2 |
| Mediastinal | 9 | – |
| Intraabdominal | 18 | – |
| Exrtanodal sites | ||
| Tonsil | 3 | 1 |
| Nasopharynx | 3 | 2 |
| Soft tissue | 1 | 1 |
| Bone | 5 | 1 |
| Pleura | 3 | 1 |
| Treatment (number of cases)a | ||
| Surgery alone | 21/76 | – |
| Surgery plus adjuvant therapy | 18/76 | 1/5 |
| Radiation therapy alone | 6/76 | 1/5 |
| Chemotherapy alone | 26/76 | 2/5 |
| Chemotherapy plus radiation therapy | 2/76 | 1/5 |
| No treatment | 2/76 | – |
| Unknown | 1/76 | – |
XML Download